Archive
Faceted archive
267 documents matching
Undated
IN FORCE
194 Vigil on the activities of distribution & sale of suspected spurious Tocilizumab 400 mg/20 ml Injections in India 2021-Dec-28 404 KB
Vigil on the activities of distribution & sale of suspected spurious Tocilizumab 400mg/20mlI Injections in India
Roche Products (India) Pvt. Ltd.Cipla Ltd.
IN FORCE
174 Classification of Medical Device Pertaining to non-sterile, non-powered, hand-held or hand-manipulated Surgical Instruments for general use intended to be used in various general surgical procedur
IN FORCE
173 Report of National List of Essential Medicines 2022 2022-Sep-13 8599 KB
IN FORCE
62 DCGI Public Hearing Form for applicants 2025-Jul-07 563 KB
IN FORCE
102 PRO feedback form Internal and Pro feedback form External 2024-Jul-26 909 KB
IN FORCE
158 Evaluation of 16 Fixed Dose Combinations (FDCs) by DTAB Sub-Committee which were earlier considered as irrational in the Expert Commiteee report of the Prof.Kokate Committee 2023-Mar-31 4207 KB
IN FORCE
200 Notice regarding Review of regulatory regime for drug approval 2021-Oct-14 348 KB
IN FORCE
172 National List of Essential Medicines 2022 2022-Sep-13 4579 KB
IN FORCE
166 Registration of Medical Device Testing Laboratory in Form MD-40 as per Medical Devices Rules (MDR) 2017 for Testing of Medical Devices on behalf of the manufacturer 2022-Dec-22 412 KB
IN FORCE
90 Grant of manufacturing licences for Large Volume Parenterals (Form 28D/Form 28DA) and endorsement of additional products in the licence through ONDLS portal 2025-Jan-07 138 KB
IN FORCE
129 Evaluation of certain pre 1988 permitted Fixed Dose Combinations FDCs de novo for manufacture for sale in the country without due approval from Central Licensing Authority 2024-Jan-11 2341 KB
Evaluation of certain pre 1988 permitted Fixed Dose Combinations (FDCs) de novo for manufacture for sale in the country without due approval from Central Licensing Authority -regarding.
IN FORCE
146 Voluntary Recall of Digene Gel manufactured by M/s Abbott India Limited, L-18/19, Verna Industrial Estate, Salcette, Goa-403722 2023-Aug-31 1049 KB
Voluntary Recall of Digene Gel manufactured by M/s Abbott India Limited, L-18 /19, verna Industrial Estate, Salcette, Goa-403722 -reg.-
Abbott India Ltd.
IN FORCE
105 DTAB Sub-Committee to examine the proposal to regulate antibiotic and its irrational use date 16 may 2024 2024-May-16 447 KB
IN FORCE
7 Disposal/Rejection of Long Pending Applications on SUGAM Portal Awaiting Query Response 2026-May-04 779 KB
IN FORCE
17 Testing Laboratories approved by Statas&UT in Form 37 of Drugs Rule 1945 and Cos 23 of Cosmetics Rule 2020 2026-Mar-10 432 KB
HS 88 Analys Lab Pvt. Ltd.Biocon Biosphere Ltd.Chalapathi institute of Pharmaceutical
IN FORCE
91 Updation of exisiting risk based classification list_draft_dated 06 01 2025 for stakeholder comments 2025-Jan-06 3025 KB
IN FORCE
32 List of Ethics Committees cancelled by CLA 2025-Dec-10 74 KB
IN FORCE
51 Availability of Not Standard Quality (NSQ) Alert on New Link in CDSCO Website 2025-Aug-28 2245 KB
IN FORCE
5 Appointment of CPIO for the purpose of RTI(Technical) Matters 2026-May-12 94 KB
IN FORCE
65 Antimicrobial Resistance AMR Mitigation 2025-Jun-05 559 KB
IN FORCE
64 To Share the list of drug products manufacturing permissions issued by State licensing Authority SLA/FDA including antibiotics, FDCs and their premixes for Veterinary use 2025-Jun-05 580 KB
To share the list of drug products manufacturing permissions issued by State Licensing Authority (SLA)/FDA including antibiotics, FDCs, & their premixes for veterinary use
IN FORCE
186 Updated list of laboratories for conducting Performance evaluation of IVD reagents/kit 2022-May-05 208 KB
IN FORCE
132 Submission of ppt via E-Vartalap Sugam Portal 2023-Dec-19 298 KB
IN FORCE
48 Stickering on Medical Products due to reduction in Goods Service Tax (GST) rate 2025-Sep-11 86 KB
IN FORCE
199 Regulation of CT scan equipment_All Implantable Devices_MRI equipment etc. as Drugs with effect from April 1st 2021 2021-Nov-03 246 KB
IN FORCE
18 Alert on theft of Lantus® SoloStar® (Insulin Glargine Injection IP, râDNA origin, 100 IU/mL Batch No. 5F0347B of M/s Sanofi India Limited during transit 2026-Mar-03 69 KB
Sanofi India Ltd.
IN FORCE
60 THE SUBJECT EXPERT COMMITTEES GUIDANCE DOCUMENT 2025-Jul-17 418 KB
IN FORCE
98 Approved panel of experts for the Subject Expert Committees 2024-Aug-29 510 KB
IN FORCE
26 Risk classification list of medical devices pertaining to Oncology 2026-Jan-02 308 KB
IN FORCE
36 Risk based classification list of Class A(non-sterile and non-measuring) medical device 2025-Oct-31 1069 KB
IN FORCE
176 Classification of Medical Device Pertaining to Rehabilitation under the Provisions of Medical Devcies Rules 2017 2022-Aug-04 852 KB
IN FORCE
10 Regulation & Mandatory Registration of Licensed Blood Centres on the e-RaktKosh Portal 2026-Mar-18 5792 KB
IN FORCE
35 Risk classification list of medical devices pertaining to Radiotherapy 2025-Nov-27 389 KB
IN FORCE
115 Implementation and effective use of RTI-MIS Portal (e-Portal) for disposal of all RTI including Physical RTI through RTI-MIS across all the CDSCO offices as per DoPT Order dated 12th August 2013 u
IN FORCE
137 Appointment of CPIO and CAPIO for the purpose of RTI for the O/o. Asstt. Drugs Controller (India), CDSCO, Airport, Aircargo, Mumbai 2023-Nov-24 827 KB
IN FORCE
94 Reconstitution of Central Expert Committee to determine the quantum of compensation in respect of faulty ASR Hip implant manufactured by M/s. DePuy international Limited U.K now M/s. Johnson & John
Reconstitution of "Central Expert Committee" to determine the quantum of
Johnson & Johnson Pvt. Ltd.DePuy lnternational Ltd.DePuy Medical Pvt. Ltd.
IN FORCE
71 Public Notice on PRO Schedule 2025-Apr-30 349 KB
IN FORCE
2 Use of Cosmetics 2026-May-19 336 KB
IN FORCE
30 Compounding of Offences under the Drugs and Cosmetics Act, 1940 in accordance with the Drugs and Cosmetics (Compounding of Offences) Rules, 2025 2026-Jan-01 348 KB
IN FORCE
193 Evaluation of certain pre 1988 permitted Fixed Dose Combinations (FDCs) de novo for manufacture for sale in the country without due approval from Central Licensing Authority regarding 2022-Jan-06
Evaluation of certain pre 1988 permitted Fixed Dose Combinations (FDCs) de novo for manufacture for sale in the country without due approval from Central Licensing Authority -regarding.
IN FORCE
13 Transfer of certain functions and delegation of powers to the zonal offices of CDSCO under Rule 22 of the Drugs and Cosmetics Rules, 1945 2026-Mar-13 271 KB
IN FORCE
107 List of meetings of Expert Committee for examination of vaccine PSUR 2023-24 2024-May-15 7 KB
IN FORCE
130 PRO Details of Zonal, Sub zonal offices of CDSCO 2024-Jan-09 26 KB
IN FORCE
100 Names of countries under the Rule 101 of New Drugs and Clinical Trial Rules 2019 related to new drug approval 2024-Aug-07 280 KB
IN FORCE
183 Classification of Medical Device Pertaining to Obstetrical and Gynecological Under the provision of Medical Devices Rules 2017 2022-Jun-03 529 KB
IN FORCE
167 Classification of Medical Device pertaining to Oncology under the provisions of Medical Devices Rules, 2017 2022-Oct-11 817 KB
IN FORCE
99 Appointment of CPIO for the purpose of RTI Technical Matters 7 Aug 24 2024-Aug-07 96 KB
IN FORCE
165 Inspection/Audits of Pharmacovigilane(PV) system of importers and manufactures of human vaccine 2022-Dec-28 322 KB
IN FORCE
177 Notice dated July 11 2022 2022-Jul-11 370 KB
IN FORCE
143 Notice regaring submission of documents in scan copy 2023-Oct-12 568 KB
Page 2 / 6 ← Previous Next →